Cellid Co (299660.KQ) Stock Price

Cellid Co Price

KOSDAQ·CLOSED
1,876.00
​
Market closed

Over the last 10 years Cellid Co grew revenue by 30.0% annually, reaching 8.84 B KRW. For Cellid Co, the net margin of -136.5% is up versus -175.8% a few years ago.

Cellid Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellid Co business model & stock analysis

Cellid Co Ltd, based in Seoul, South Korea, operates in the Health Care sector within the Biotechnology industry. The company develops immunotherapeutic vaccines, focusing on cancer therapeutic vaccines through its BVAC pipeline products using CeliVax technology. Listed on 20 February 2019, Cellid employs 59 full-time staff and conducts clinical research to advance its vaccine development.

Frequently asked questions about Cellid Co

Converted at the current exchange rate, the Cellid Co share trades at 1.25 EUR (1,876.00 KRW).

The Cellid Co share (299660.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (299660.KQ).

The revenue cannot currently be calculated for Cellid Co.

The profit cannot currently be calculated for Cellid Co.

The P/E ratio cannot be calculated for Cellid Co at the moment.

The P/S cannot be calculated for Cellid Co currently.

The Eulerpool Quality Score for Cellid Co is 6/10.

The ISIN of Cellid Co is KR7299660001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cellid Co is 299660.KQ. The ticker symbol is used to trade Cellid Co shares on the stock exchange.

Fair ValueTerminal
1,838.48 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
149.86 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website cellid.co.kr
Country
South Korea
Currency
KRW
Initial public offering
Feb 20, 2019
ISIN
KR7299660001
Cusip
Y1R42G106
Market capitalization
34.83 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.47
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-16.26 %
Last updated Nov 11, 2026, 6:34 PM

Cellid Co Peer Group

Cellid Co Ticker

KOSDAQ · 299660.KQ

Cellid Co FIGI

299660:KS · BBG00N0JJRG0299660:KQ · BBG00N0JJRJ7

All fundamentals and in-depth analysis of Cellid Co

Our stock analysis for Cellid Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellid Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.